NovoCure Ltd (NVCR)
18.10
+1.48
(+8.90%)
USD |
NASDAQ |
Nov 06, 16:00
18.00
-0.10
(-0.55%)
After-Hours: 20:00
NovoCure Free Cash Flow: -78.21M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
September 30, 2024 | -78.21M |
June 30, 2024 | -104.47M |
March 31, 2024 | -120.97M |
December 31, 2023 | -100.43M |
September 30, 2023 | -89.19M |
June 30, 2023 | -45.90M |
March 31, 2023 | -4.605M |
December 31, 2022 | 9.43M |
September 30, 2022 | 19.70M |
June 30, 2022 | 24.08M |
March 31, 2022 | 36.01M |
December 31, 2021 | 58.59M |
September 30, 2021 | 106.18M |
June 30, 2021 | 113.26M |
March 31, 2021 | 99.13M |
December 31, 2020 | 84.18M |
September 30, 2020 | 40.36M |
June 30, 2020 | 24.38M |
Date | Value |
---|---|
March 31, 2020 | 21.62M |
December 31, 2019 | 16.14M |
September 30, 2019 | 27.25M |
June 30, 2019 | 19.34M |
March 31, 2019 | 3.715M |
December 31, 2018 | -8.576M |
September 30, 2018 | -28.44M |
June 30, 2018 | -31.93M |
March 31, 2018 | -30.09M |
December 31, 2017 | -40.50M |
September 30, 2017 | -52.78M |
June 30, 2017 | -91.90M |
March 31, 2017 | -120.79M |
December 31, 2016 | -125.26M |
September 30, 2016 | -137.37M |
June 30, 2016 | -123.71M |
March 31, 2016 | -113.85M |
December 31, 2015 | -110.16M |
Free Cash Flow Range, Past 5 Years
-120.97M
Minimum
Mar 2024
113.26M
Maximum
Jun 2021
5.464M
Average
20.66M
Median
Free Cash Flow Benchmarks
Abbott Laboratories | 6.486B |
Perspective Therapeutics Inc | -24.58M |
Retractable Technologies Inc | 4.325M |
Xtant Medical Holdings Inc | -17.52M |
Catheter Precision Inc | -7.444M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 10.38M |
Cash from Investing (Quarterly) | 10.19M |
Cash from Financing (Quarterly) | 0.10M |
Free Cash Flow Per Share (Quarterly) | -0.0028 |
Free Cash Flow to Equity (Quarterly) | -1.319M |
Free Cash Flow to Firm (Quarterly) | -0.307M |
Free Cash Flow Yield | -4.02% |